外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系

doi:10.6040/j.issn.1671-7554.0.2016.355

摘要/Abstract

摘要： 目的探讨外周血淋巴细胞/单核细胞比值(LMR)与恶性胸膜间皮瘤(MPM)患者预后的关系。方法收集85例MPM患者的临床资料和随访资料,根据外周血LMR值将患者分为高LMR组(n=27)和低LMR组(n=58),对比分析两组临床病理资料和生存时间,并采用Cox回归模型分析LMR及其他临床病理因素与患者总生存期的关系。结果两组性别、功能状态(PS)评分、淋巴细胞计数和单核细胞计数差异有统计学意义(P<0.05)。高LMR组中位生存时间(27个月)显著长于低LMR组(9个月)(P<0.001)。在不同组织学类型和肿瘤分期患者中,高LMR组中位生存时间均长于低LMR组(P<0.05)。多因素分析显示,LMR是影响MPM患者总生存期的独立因素(HR: 0.277; 95% CI: 0.142~0.538; P<0.001)。结论外周血LMR可作为反映MPM患者生存预后的生物学标志物。

关键词: 总生存期, 胸腔镜, 淋巴细胞/单核细胞比值, 恶性胸膜间皮瘤, 预后

Abstract: Objective To explore the correlation between lymphocyte-to-monocyte ratio(LMR)in peripheral blood and prognosis of malignant pleural mesothelioma(MPM). Methods Clinicopathological data of 85 patients with MPM were retrospectively analyzed. According to the LMR in peripheral blood, the patients were divided into two groups: high LMR group(n=27)and low LMR group(n=58). The clinicopathological data and overall survival of the two groups were compared. The correlation between the clinicopathological data and the overall survival was analyzed with Cox regression model. Results Significant differences were observed between the two groups in gender, performance status(PS)score, absolute lymphocyte count and absolute monocyte count(P<0.05). The median overall survival of patients with high LMR was significantly longer than that of patients with low LMR(27 months vs 9 months, P<0.001). Of patients with various histological types and tumor stages, the median overall survival of patients with high LMR was significantly longer than that of patients with low LMR. Multivariate analysis showed that LMR was an independent prognostic factor associated with prognosis of MPM(HR: 0.277; 95% CI: 0.142-0.538; P<0.001). Conclusion LMR in peripheral blood is a biological marker for the prognosis of MPM.

Key words: Thoracoscopy, Lymphocyte-to-monocyte ratio, Malignant pleural mesothelioma, Prognosis, Overall survival

中图分类号:

R734.3

王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报（医学版）, 2016, 54(8): 72-77.

WANG Wen, LIU Yao, LONG Fei, MA Weixia, SU Lili. Correlation between lymphocyte-to-monocyte ratio in peripheral blood and prognosis of malignant pleural mesothelioma[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 72-77.

参考文献

[1] 曲宸绪, 周珊珊, 乔友林. 我国部分地区胸膜间皮瘤的描述流行病学分析[J]. 肿瘤研究与临床, 2004, 16(2): 143-144.
[2] 张盼, 王静. 胸膜间皮瘤的研究进展[J]. 肿瘤基础与临床, 2011, 24(1): 81-82.
[3] Nishijima TF, Muss HB, Shachar SS, et al. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis[J]. Cancer Treat Rev, 2015, 41(10): 971-978.
[4] Cao C, Tian D, Park J, et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma[J]. Lung Cancer, 2014, 83(2): 240-245.
[5] Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group[J]. Chest, 1995, 108(4): 1122-1128.
[6] 郭靓, 钱露, 郭宁. 炎症——肿瘤恶性演进的推手[J]. 中国肿瘤生物治疗杂志, 2013, 20(3): 259-265. GUO Liang, QIAN Lu, GUO Ning. Inflammation: A promoter in malignant progression of tumor[J]. Chin J Cancer Biother, 2013, 20(3): 259-265.
[7] Li ZM, Huang JJ, Xia Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP[J]. PLoS ONE, 2012, 7(7): e41658. doi: 10.1371/journal.pone.0041658.
[8] Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkins lymphoma[J]. Haematologica, 2012, 97(2): 262-269.
[9] Stotz M, Szkandera J, Stojakovic T, et al. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer[J]. Clin Chem Lab Med, 2015, 53(3): 499-506.
[10] Zhou X, Du Y, Xu J, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage Ⅱ/Ⅲ gastric cancer[J]. Tumour Biol, 2014, 35(11): 11659-11666.
[11] Hu P, Shen H, Wang G, et al. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study[J]. PLoS ONE, 2014, 9(9): e108062. doi: 10.1371/journal.pone.0108062.
[12] Lin GN, Peng JW, Xiao JJ, et al. Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet[J]. Med Oncol, 2014, 31(7): 70.
[13] Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
[14] Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
[15] Schmidt H, Bastholt L, Geertsen P, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model[J]. Br J Cancer, 2005, 93(3): 273-278.
[16] Lee YY, Choi CH, Sung CO, et al. Prognostic value of pretreatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level[J]. Gynecol Oncol, 2012, 124(1): 92-97.
[17] Koh YW, Shin SJ, Park C, et al. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages[J]. Hematol Oncol, 2014, 32(4): 178-186.
[18] Chanmee T, Ontong P, Konno K, et al. Tumor-associated macrophages as major players in the tumor microenvironment[J]. Cancers, 2014, 6(3): 1670-1690.

相关文章 15

[1]	梁晨,姚丽娟,吕龙飞,唐泽,秦达,崔有斌,余孝淇. 三维重建联合CT引导下穿刺定位在微创治疗肺磨玻璃结节中的应用[J]. 山东大学学报 (医学版), 2026, 64(5): 74-82.
[2]	李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[3]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[4]	王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[5]	贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[6]	杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[7]	杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[8]	山东省腔镜外科质量控制中心胸腔镜委员会. 山东省VATS/RATS非小细胞肺癌围术期质量控制指标专家共识(2025版)[J]. 山东大学学报 (医学版), 2025, 63(12): 1-5.
[9]	刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.
[10]	陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[11]	郭姝画,樊扬,田风,王传新,杜鲁涛,李培龙,郭兴,徐硕. 微原纤维相关蛋白3在调控胶质瘤干细胞间充质表型转化中的作用[J]. 山东大学学报 (医学版), 2024, 62(6): 9-16.
[12]	魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[13]	白晓亮,孙盼盼,王泓力,龚顺之,孙云起,舒梦,戚晓良. 内科胸腔镜下内脏神经切断术的动物实验[J]. 山东大学学报 (医学版), 2024, 62(4): 9-13.
[14]	刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[15]	杨雪彦,吴寅平,吕丽,赵泽华,马行宇,李凤彩,王凯,范玉琛. 单核细胞与淋巴细胞比值动态变化对慢加急性乙型肝炎肝衰竭预后的诊断价值[J]. 山东大学学报 (医学版), 2024, 62(3): 61-69.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed